» Articles » PMID: 32187054

Advances in the Role of Helper T Cells in Autoimmune Diseases

Overview
Specialty General Medicine
Date 2020 Mar 19
PMID 32187054
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune diseases are primary immune diseases in which autoreactive antibodies or sensitized lymphocytes destroy and damage tissue and cellular components, resulting in tissue damage and organ dysfunction. Helper T cells may be involved in the pathogenesis of autoimmune diseases under certain conditions. This review summarizes recent research on the role of helper T cells in autoimmune diseases from two aspects, helper T cell-mediated production of autoantibodies by B cells and helper T cell-induced activation of abnormal lymphocytes, and provides ideas for the treatment of autoimmune diseases. The abnormal expression of helper T cells promotes the differentiation of B cells that produce autoantibodies, which leads to the development of different diseases. Among them, abnormal expression of Th2 cells and T follicular helper cells is more likely to cause antibody-mediated autoimmune diseases. In addition, abnormal activation of helper T cells also mediates autoimmune diseases through the production of abnormal cytokines and chemokines. Helper T cells play an essential role in the pathogenesis of autoimmune diseases, and a full understanding of their role in autoimmune diseases is helpful for providing ideas for the treatment of autoimmune diseases.

Citing Articles

Interleukin-27 and Autoimmune Disorders: A Compressive Review of Immunological Functions.

Yazdanpanah E, Pazoki A, Dadfar S, Nemati M, Sajad Siadati S, Tarahomi M Biomolecules. 2025; 14(12.

PMID: 39766196 PMC: 11672993. DOI: 10.3390/biom14121489.


Debate on the relationship between infection and inflammatory bowel disease: a bibliometric analysis.

Wang Z, Zhao S, Zhong X, Su Y, Song Y, Li J Front Microbiol. 2024; 15:1479941.

PMID: 39569001 PMC: 11576472. DOI: 10.3389/fmicb.2024.1479941.


IL-17 and IL-38 gene polymorphisms in thyroid-associated ophthalmopathy.

Mussakulova A, Balmukhanova A, Aubakirova A, Khamdiyeva O, Zhunussova G, Balmukhanova A Int Ophthalmol. 2024; 44(1):379.

PMID: 39292290 DOI: 10.1007/s10792-024-03317-0.


Research progress of T cell autophagy in autoimmune diseases.

Zhao X, Ma D, Yang B, Wang Y, Zhang L Front Immunol. 2024; 15:1425443.

PMID: 39104538 PMC: 11298352. DOI: 10.3389/fimmu.2024.1425443.


Mathematical modeling in autoimmune diseases: from theory to clinical application.

Ugolkov Y, Nikitich A, Leon C, Helmlinger G, Peskov K, Sokolov V Front Immunol. 2024; 15:1371620.

PMID: 38550585 PMC: 10973044. DOI: 10.3389/fimmu.2024.1371620.


References
1.
Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, OConnor K . Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016; 196(5):2075-84. PMC: 4761502. DOI: 10.4049/jimmunol.1501339. View

2.
Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y . Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2002; 52(1):65-70. PMC: 1773503. DOI: 10.1136/gut.52.1.65. View

3.
Hasegawa M, Takehara K . Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines. Semin Arthritis Rheum. 2012; 42(3):281-96. DOI: 10.1016/j.semarthrit.2012.03.014. View

4.
Jiang C, Wang H, Xue M, Lin L, Wang J, Cai G . Reprograming of peripheral Foxp3 regulatory T cell towards Th17-like cell in patients with active systemic lupus erythematosus. Clin Immunol. 2019; 209:108267. DOI: 10.1016/j.clim.2019.108267. View

5.
Kordasti S, Marsh J, Al-Khan S, Jiang J, Smith A, Mohamedali A . Functional characterization of CD4+ T cells in aplastic anemia. Blood. 2011; 119(9):2033-43. DOI: 10.1182/blood-2011-08-368308. View